Chen B, Greenside P, Paik H, Sirota M, Hadley D, Butte A J
Institute for Computational Health Sciences, University of California San Francisco, San Francisco, California, USA.
Biomedical Informatics Training Program, Stanford University School of Medicine Stanford, California, USA.
CPT Pharmacometrics Syst Pharmacol. 2015 Oct;4(10):576-84. doi: 10.1002/psp4.12009. Epub 2015 Sep 29.
A central premise in systems pharmacology is that structurally similar compounds have similar cellular responses; however, this principle often does not hold. One of the most widely used measures of cellular response is gene expression. By integrating gene expression data from Library of Integrated Network-based Cellular Signatures (LINCS) with chemical structure and bioactivity data from PubChem, we performed a large-scale correlation analysis of chemical structures and gene expression profiles of over 11,000 compounds taking into account confounding factors such as biological conditions (e.g., cell line, dose) and bioactivities. We found that structurally similar compounds do indeed yield similar gene expression profiles. There is an ∼20% chance that two structurally similar compounds (Tanimoto Coefficient ≥ 0.85) share significantly similar gene expression profiles. Regardless of structural similarity, two compounds tend to share similar gene expression profiles in a cell line when they are administrated at a higher dose or when the cell line is sensitive to both compounds.
系统药理学的一个核心前提是结构相似的化合物具有相似的细胞反应;然而,这一原则往往并不成立。细胞反应最广泛使用的指标之一是基因表达。通过将基于综合网络的细胞特征库(LINCS)的基因表达数据与来自PubChem的化学结构和生物活性数据相结合,我们对11000多种化合物的化学结构和基因表达谱进行了大规模的相关性分析,同时考虑了生物条件(如细胞系、剂量)和生物活性等混杂因素。我们发现结构相似的化合物确实会产生相似的基因表达谱。两个结构相似的化合物(Tanimoto系数≥0.85)有20%的可能性共享显著相似的基因表达谱。无论结构相似性如何,当两种化合物以较高剂量给药或细胞系对这两种化合物都敏感时,它们在细胞系中往往会共享相似的基因表达谱。